doi: 10.1016/j.beha.2007.02.002.
Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL)
Affiliations
- PMID: 17707834
- DOI: 10.1016/j.beha.2007.02.002
Item in Clipboard
Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL)
Best Pract Res Clin Haematol.
2007 Sep.
Abstract
During the past 10 years, significant progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options in chronic lymphocytic leukemia (CLL). These developments have led to revision of the National Cancer Institute-sponsored Working Group (NCI-WG) guidelines on CLL established in 1988 and 1996. The update of these guidelines will clarify the role of new prognostic markers in CLL, improve the definitions of response and refractory disease, and add information on the prevention and management of infectious and autoimmune complications.
Similar articles
-
Current guidelines in defining therapeutic strategies.Hematol Oncol Clin North Am. 2004 Aug;18(4):881-93, ix. doi: 10.1016/j.hoc.2004.04.006. Hematol Oncol Clin North Am. 2004. PMID: 15325704 Review.
-
CLL response criteria.Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 10; suppl 12. Clin Adv Hematol Oncol. 2006. PMID: 16830419 No abstract available.
-
Study design in chronic lymphocytic leukemia.Nouv Rev Fr Hematol (1978). 1988;30(5-6):407-10. Nouv Rev Fr Hematol (1978). 1988. PMID: 3065736 Review.
-
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23. Blood. 2008. PMID: 18216293 Free PMC article.
-
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.Am J Hematol. 1988 Nov;29(3):152-63. doi: 10.1002/ajh.2830290307. Am J Hematol. 1988. PMID: 3189311
Cited by
-
Dynamic Bayesian networks for prediction of health status and treatment effect in patients with chronic lymphocytic leukemia.Sci Rep. 2022 Feb 2;12(1):1811. doi: 10.1038/s41598-022-05813-8. Sci Rep. 2022. PMID: 35110619 Free PMC article.
-
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?Leuk Res. 2008 Sep;32(9):1458-61. doi: 10.1016/j.leukres.2007.11.030. Epub 2008 Jan 7. Leuk Res. 2008. PMID: 18179821 Free PMC article.
-
Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia.Adv Hematol. 2010;2010:272517. doi: 10.1155/2010/272517. Epub 2010 Sep 20. Adv Hematol. 2010. PMID: 20886004 Free PMC article.
-
Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH.Int J Hematol Oncol. 2017 Dec;6(4):105-111. doi: 10.2217/ijh-2017-0019. Epub 2017 Dec 21. Int J Hematol Oncol. 2017. PMID: 30302231 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
